We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$773M
AUM Growth
-$71.9M
Cap. Flow
-$78.8M
Cap. Flow %
-10.19%
Top 10 Hldgs %
77.44%
Holding
144
New
42
Increased
11
Reduced
17
Closed
69

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.4M
2
SN icon
SharkNinja
SN
+$14.8M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$11.2M
4
ODD icon
ODDITY Tech
ODD
+$8.91M
5
GE icon
GE Aerospace
GE
+$8.43M

Sector Composition

Rank Sector Weight
1 Healthcare 6.59%
2 Technology 4.5%
3 Industrials 3.66%
4 Financials 3.35%
5 Consumer Discretionary 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSBD icon
51
Palmer Square Capital BDC
PSBD
$320M
$1.29M 0.17%
79,947
-45,053
-36% -$742K
PCRX icon
52
Pacira BioSciences
PCRX
$997M
$1.14M 0.15%
+40,000
New +$1.14M
RZLT icon
53
Rezolute
RZLT
$452M
$1.07M 0.14%
+250,000
New +$859K
JILL icon
54
J. Jill
JILL
$283M
$1.05M 0.14%
+30,000
New +$919K
SVCO
55
Silvaco Group
SVCO
$256M
$1.03M 0.13%
+57,061
New +$1.04M
SEDG icon
56
SolarEdge
SEDG
$1.95B
$1.01M 0.13%
+40,000
New +$2.08M
NEE.PRS
57
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.1B
$990K 0.13%
+20,000
New +$1M
PLGO
58
Pelagos Insurance Capital
PLGO
$2.14B
$979K 0.13%
+60,052
New +$1.06M
FSM icon
59
Fortuna Silver Mines
FSM
$3.07B
$978K 0.13%
+200,000
New +$1.01M
AMCX icon
60
AMC Global Media
AMCX
$489M
$966K 0.12%
+100,000
New +$1.32M
CNTA
61
DELISTED
Centessa Pharmaceuticals
CNTA
$932K 0.12%
+103,191
New +$979K
RAPP
62
Rapport Therapeutics
RAPP
$2.18B
$930K 0.12%
+40,000
New +$926K
BE icon
63
Bloom Energy
BE
$64.6B
$918K 0.12%
+75,000
New +$956K
CCC
64
CCC Intelligent Solutions
CCC
$4.08B
$833K 0.11%
+75,000
New +$854K
GOSS icon
65
Gossamer Bio
GOSS
$87M
$775K 0.1%
859,854
-2,600,000
-75% -$1.95M
LFST icon
66
Lifestance Health
LFST
$4.14B
$737K 0.1%
+150,000
New +$904K
ANNX icon
67
Annexon
ANNX
$886M
$735K 0.1%
+150,000
New +$776K
KBDC
68
Kayne Anderson BDC
KBDC
$937M
$718K 0.09%
+45,000
New +$730K
URGN icon
69
UroGen Pharma
URGN
$2.29B
$680K 0.09%
+40,500
New +$576K
PAL
70
Proficient Auto Logistics
PAL
$204M
$562K 0.07%
+35,000
New +$534K
UNCY icon
71
Unicycive Therapeutics
UNCY
$139M
$501K 0.06%
100,000
CMPX icon
72
Compass Therapeutics
CMPX
$387M
$500K 0.06%
500,000
RGLS
73
DELISTED
Regulus Therapeutics
RGLS
$352K 0.05%
197,049
-427,951
-68% -$993K
WBTN
74
WEBTOON Entertainment Inc
WBTN
$1.21B
$342K 0.04%
+15,000
New +$344K
ABSI icon
75
Absci
ABSI
$1.51B
-500,000
Closed -$2.84M

Similar funds

Monashee Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Monashee Investment Management held 144 positions worth $773M, down 8.5% from $845M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Monashee Investment Management withdrew a net $78.8M in Q2 2024, closing 69 positions and reducing 17 holdings. Its most notable exit was AB InBev, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Monashee Investment Management opened a new position in Ares Management worth $10M.

  • Monashee Investment Management's largest Q2 2024 buy was Ares Management: 75,000 shares worth $10M.
  • Monashee Investment Management added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $11.8M increase.
  • Monashee Investment Management's biggest Q2 2024 reduction was REV Group, cutting an estimated $4.76M.
  • Monashee Investment Management fully exited AB InBev in Q2 2024, selling an estimated $16.4M.
  • Monashee Investment Management's ten largest holdings make up 77% of its $773M portfolio in Q2 2024.
  • Monashee Investment Management opened 42 new positions and closed 69 in Q2 2024.
  • Monashee Investment Management's portfolio value fell 8.5% quarter-over-quarter to $773M.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.